Apotex has taken a major step to bolster its innovative interests with the acquisition of fellow Canadian firm and specialty branded player Searchlight Pharma.
Apotex has struck a deal to acquire fellow private Canadian company and branded player Searchlight Pharma, in a move that the generics and biosimilars specialist says will “create a Canadian health champion spanning generic, biosimilar and branded pharmaceuticals.”
Financial details of the transaction were not disclosed, although a report in Canada’s Globe and Mail valued Searchlight at over...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
